Our results indicated that larger acute increases in IL-6 were associated with better improvement in affective and cognitive symptoms of depression, in individuals with relatively higher concentrations of IL-6 at post-treatment, whereas no significant association was detected in individuals with lower post-treatment IL-6. The gene discussed is IL6; the disease is depressive symptom measurement.